Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R-91154
1. Prosynap
2. 144665-07-6
3. R-87926
4. Chembl281724
5. V2sib71583
6. (2s)-1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol
7. (s)-1-(4-(benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol
8. Lubeluzole [inn]
9. Lubeluzol
10. Lubeluzole [usan:inn:ban]
11. Unii-v2sib71583
12. Prosynap (tn)
13. R 87926
14. Lubeluzole [mi]
15. Lubeluzole Dihydrochloride
16. Lubeluzole (usan/inn)
17. Lubeluzole [usan]
18. Lubeluzole [mart.]
19. Lubeluzole [who-dd]
20. Schembl159725
21. Dtxsid60162779
22. Chebi:135703
23. Bdbm50066066
24. Jk-8792
25. Ncgc00487398-02
26. (+)-(s)-4-(2-benzothiazolylmethylamino)-alpha-((3,4-difluorophenoxy)methyl)-1-piperidineethanol
27. 1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-alpha-((3,4-difluorophenoxy)methyl)-, (s)-
28. Hy-105084
29. Cs-0024938
30. D04789
31. Q6695177
32. (+)-(s)-4-(2-benzothiazolylmethylamino)-.alpha.-((3,4-difluorophenoxy)methyl)-1-piperidineethanol
33. (2s)-1-[4-(1,3-benzothiazol-2-yl-methylamino)piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol
34. (s)-1-[4-(benzothiazol-2-yl-methyl-amino)-piperidin-1-yl]-3-(3,4-difluoro-phenoxy)-propan-2-ol
35. 1-[4-(benzothiazol-2-yl-methyl-amino)-piperidin-1-yl]-3-(3,4-difluoro-phenoxy)-propan-2-ol(lubeluzole)
36. 1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-.alpha.-((3,4-difluorophenoxy)methyl)-, (s)-
| Molecular Weight | 433.5 g/mol |
|---|---|
| Molecular Formula | C22H25F2N3O2S |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 433.16355455 g/mol |
| Monoisotopic Mass | 433.16355455 g/mol |
| Topological Polar Surface Area | 77.1 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 541 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
ABOUT THIS PAGE
88
PharmaCompass offers a list of Lubeluzole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lubeluzole manufacturer or Lubeluzole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lubeluzole manufacturer or Lubeluzole supplier.
PharmaCompass also assists you with knowing the Lubeluzole API Price utilized in the formulation of products. Lubeluzole API Price is not always fixed or binding as the Lubeluzole Price is obtained through a variety of data sources. The Lubeluzole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lubeluzole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lubeluzole, including repackagers and relabelers. The FDA regulates Lubeluzole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lubeluzole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lubeluzole supplier is an individual or a company that provides Lubeluzole active pharmaceutical ingredient (API) or Lubeluzole finished formulations upon request. The Lubeluzole suppliers may include Lubeluzole API manufacturers, exporters, distributors and traders.
click here to find a list of Lubeluzole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lubeluzole DMF (Drug Master File) is a document detailing the whole manufacturing process of Lubeluzole active pharmaceutical ingredient (API) in detail. Different forms of Lubeluzole DMFs exist exist since differing nations have different regulations, such as Lubeluzole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lubeluzole DMF submitted to regulatory agencies in the US is known as a USDMF. Lubeluzole USDMF includes data on Lubeluzole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lubeluzole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lubeluzole suppliers with USDMF on PharmaCompass.
Lubeluzole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lubeluzole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lubeluzole GMP manufacturer or Lubeluzole GMP API supplier for your needs.
A Lubeluzole CoA (Certificate of Analysis) is a formal document that attests to Lubeluzole's compliance with Lubeluzole specifications and serves as a tool for batch-level quality control.
Lubeluzole CoA mostly includes findings from lab analyses of a specific batch. For each Lubeluzole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lubeluzole may be tested according to a variety of international standards, such as European Pharmacopoeia (Lubeluzole EP), Lubeluzole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lubeluzole USP).
